Profile data is unavailable for this security.
About the company
Beijing Balance Medical Technology Co Ltd is a China-based company mainly engaged in the research and development (R&D) and production of animal derived interventional medical devices. The Company's products cover three fields: heart valve replacement and repair, implantable interventional therapy for congenital heart disease and surgical soft tissue repair. The heart valve replacement and repair products include artificial biological heart valves and valve forming rings. The implantable interventional therapy products for congenital heart disease include cardiothoracic surgical biological patch, outflow tract single valve patch, atrial defect occlude and others. The surgical soft tissue repair products include neurosurgical biological patch, biological hernia patch and others. The Company operates its businesses mainly in the domestic market.
- Revenue in CNY (TTM)405.57m
- Net income in CNY103.55m
- Incorporated2005
- Employees473.00
- LocationBeijing Balance Medical Technology Co LtdNo.2, Huachang Road, Scienceand Technology Park East Zone, ChangpinBeijing 102200ChinaCHN
- Phone+86 1 060735920
- Fax+86 1 089700424
- Websitehttps://www.balancemed.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Wandong Medical Technolgy Co Ltd | 1.40bn | 184.09m | 12.30bn | 1.06k | 66.79 | 2.60 | -- | 8.76 | 0.262 | 0.262 | 2.00 | 6.74 | 0.2647 | 2.76 | 4.01 | 1,325,746.00 | 3.50 | 5.30 | 3.91 | 6.21 | 38.83 | 45.21 | 13.22 | 16.46 | 9.48 | -- | 0.0179 | 35.82 | 10.30 | 5.32 | 7.51 | 4.22 | -16.66 | 5.39 |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.27bn | 657.34m | 13.31bn | 908.00 | 19.85 | 3.42 | -- | 10.50 | 5.44 | 5.44 | 10.59 | 31.54 | 0.371 | 1.33 | 6.51 | 1,396,816.00 | 19.00 | 17.68 | 21.55 | 19.43 | 74.51 | 76.60 | 51.21 | 42.25 | 5.49 | -- | 0.0067 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
| Sansure Biotech Inc | 1.41bn | 259.42m | 13.73bn | 2.01k | 52.67 | 1.87 | -- | 9.76 | 0.4475 | 0.4475 | 2.44 | 12.62 | 0.1667 | 0.878 | 2.03 | 701,473.70 | 2.52 | 26.74 | 2.79 | 30.97 | 76.43 | 67.47 | 15.12 | 42.01 | 7.45 | -- | 0.0583 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.75bn | 430.21m | 13.85bn | 2.16k | 35.40 | 2.74 | -- | 5.04 | 1.86 | 1.86 | 11.89 | 24.07 | 0.3833 | 1.60 | 7.60 | 1,272,966.00 | 5.60 | 4.84 | 6.60 | 5.50 | 68.97 | 72.04 | 14.61 | 16.36 | 3.71 | -- | 0.0697 | 36.86 | 24.59 | 11.24 | 130.58 | 0.0762 | 11.96 | -- |
| Micro-Tech Nanjing Co Ltd | 2.68bn | 550.49m | 13.87bn | 2.40k | 25.12 | 3.72 | -- | 5.18 | 2.94 | 2.94 | 14.30 | 19.86 | 0.6118 | 1.65 | 6.80 | 1,114,222.00 | 12.87 | 10.74 | 15.26 | 12.82 | 66.04 | 63.04 | 21.04 | 19.37 | 3.99 | -- | 0.0183 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
| iRay Technology Co Ltd | 1.82bn | 564.72m | 16.13bn | 1.66k | 30.18 | 3.51 | -- | 8.84 | 3.74 | 3.74 | 12.14 | 32.15 | 0.2544 | 1.03 | 2.56 | 1,097,588.00 | 7.81 | 12.07 | 8.48 | 13.86 | 53.92 | 55.59 | 30.71 | 34.51 | 4.23 | -- | 0.3972 | 31.52 | 20.31 | 33.51 | -5.27 | 58.58 | 107.96 | -- |
| Beijing Balance Medical Technolgy Co Ltd | 405.57m | 103.55m | 16.70bn | 473.00 | 161.36 | 14.25 | -- | 41.17 | 0.7531 | 0.7531 | 2.96 | 8.53 | 0.3183 | 1.09 | 4.94 | 857,444.60 | 7.14 | 8.06 | 7.46 | 8.40 | 88.31 | 89.41 | 22.42 | 30.02 | 8.22 | -- | 0.0091 | 69.19 | 25.57 | 27.35 | 21.09 | 28.10 | 125.94 | -- |
| Eyebright Medical Tchnlgy Beijing Co Ltd | 1.36bn | 369.60m | 17.45bn | 2.07k | 47.15 | 7.49 | -- | 12.85 | 1.95 | 1.95 | 7.17 | 12.29 | 0.4599 | 2.40 | 4.64 | 654,939.80 | 11.73 | 9.99 | 13.29 | 11.16 | 65.58 | 81.29 | 25.50 | 34.66 | 3.76 | 41.18 | 0.1904 | 19.91 | 64.14 | 49.59 | 30.63 | 71.80 | 38.83 | -- |
Data as of Nov 22 2024. Currency figures normalised to Beijing Balance Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
7.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 5.65m | 4.14% |
| Huaxia Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Mar 2024 | 1.53m | 1.12% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2024 | 845.81k | 0.62% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 790.45k | 0.58% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2024 | 752.07k | 0.55% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 344.67k | 0.25% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 297.22k | 0.22% |
| Fuanda Fund Management Co., Ltd.as of 30 Jun 2024 | 143.72k | 0.11% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 132.70k | 0.10% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 124.02k | 0.09% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
